Login
Indian pharma company advised on $394m sale of its Australian business
Indian-listed pharmaceuticals company Strides Pharma Science has been advised on the $394 million sale of its entire Australian business to Arrotex.
Jerome Doraisamy
Source: strides.com/corporate-whoweare.html
Firm: Herbert Smith Freehills (Strides Pharma Science Limited).
The transaction also involved Strides entering into a long-term preferred supplier contract with the merged entity Arrotex, which will allow Strides to continue to earn revenue from the merged business, HSF said in a statement.
Value: $394 million.
Area: Corporate.
Key players: The HSF team was comprised of lawyers from the firm's London, Melbourne, Brisbane and Sydney offices and led by London corporate partner and co-head of pharmaceuticals, Alan Montgomery, assisted by corporate associates Nishita Vasan and Martyn Jones, finance partner Will Nevin, associates Oliver Henderson, Susie Nguyen and Siqi Geng, and intellectual property of counsel Laura Deacon.
Australian legal advice was provided by corporate partner Peter Dunne, associate Wendy Tian (corporate), finance partner Phillip McMahon and associate Anthony Economou (finance), and Greenwoods & Herbert Smith Freehills director Toby Eggleston (tax).
Deal significance: Mr Montgomery said: "We are pleased to have had the opportunity to advise our longstanding client, Strides, on this important transaction, demonstrating our cross-border life sciences M&A capability and our ability to work seamlessly across multiple jurisdictions and offices."
Jerome Doraisamy
Jerome Doraisamy is the editor of Lawyers Weekly and HR Leader. He has worked at Momentum Media as a journalist on Lawyers Weekly since February 2018, and has served as editor since March 2022. In June 2024, he also assumed the editorship of HR Leader. Jerome is also the author of The Wellness Doctrines book series, an admitted solicitor in NSW, and a board director of the Minds Count Foundation.
You can email Jerome at:
